Blog
RSS FeedPosted by Michael Wonder on 21 Nov 2019
Doctors who helped develop heart drug now balk at $225,000/year price
19 November 2019 - Wearing a revolutionary-era tricorn hat, doctor Mathew Maurer stood at a lectern in front of an ...
Posted by Michael Wonder on 21 Nov 2019
Allogeneic hematopoietic cell transplantation and other expensive cellular therapies: a miracle for the few but off limits to many?
15 November 2019 - The number of patients undergoing allogeneic hematopoietic cell transplantation (HCT) for treatment of malignant and nonmalignant disorders ...
Posted by Michael Wonder on 20 Nov 2019
Top GOP senator: drug pricing action unlikely before end of year
19 November 2019 - Senator John Thune, the Senate’s No. 2 Republican, said Tuesday that it is unlikely the Senate ...
Posted by Michael Wonder on 20 Nov 2019
FDA approves first treatment for inherited rare disease
20 November 2019 - Today, the U.S. FDA granted approval to Givlaari (givosiran) for the treatment of adult patients with acute ...
Posted by Michael Wonder on 20 Nov 2019
Alkermes submits new drug application to U.S. FDA for ALKS 3831 for treatment of schizophrenia and bipolar I disorder
19 November 2019 - Alkermes today announced that it has submitted a new drug application to the U.S. FDA seeking ...
Posted by Michael Wonder on 20 Nov 2019
Newron receives FDA rare paediatric disease designation for sarizotan for the treatment of Rett syndrome
19 November 2019 - Newron announced today that the U.S. FDA has granted the rare paediatric disease designation for sarizotan, ...
Posted by Michael Wonder on 20 Nov 2019
Generic drug approvals soar, but patients still go without
19 November 2019 - Brand name makers’ patent action limits release of the lower-price medicines, hindering cost-control efforts. ...
Posted by Michael Wonder on 19 Nov 2019
Orphazyme receives breakthrough therapy designation for arimoclomol in Niemann-Pick disease Type C
19 November 2019 - Orphazyme today announces that the US FDA has granted breakthrough therapy designation for arimoclomol, an investigational drug ...
Posted by Michael Wonder on 19 Nov 2019
FDA accepts Samsung Bioepis’ BLA for SB8 bevacizumab biosimilar candidate
19 November 2019 - Samsung Bioepis today announced that the U.S. FDA has accepted for review the company’s biologics license ...
Posted by Michael Wonder on 19 Nov 2019
In a rare political move, prominent biotech venture capitalists speak out against Pelosi’s drug pricing bill
18 November 2019 - A group of top biotech venture capitalists are issuing a stark warning to Congress: They won’t ...
Posted by Michael Wonder on 19 Nov 2019
AMA develops Rx for drug prices that are high and rising
19 November 2019 - Arbitration in determining prescription drug prices is a viable mechanism to address the burden of high and ...
Posted by Michael Wonder on 19 Nov 2019
Here’s why pharmaceutical companies raise their prices so much
19 November 2019 - Yes, I’ve ranted about healthcare prices before. On more than one occasion. ...
Posted by Michael Wonder on 19 Nov 2019
AMA sharpens policy to promote reasonable drug prices
18 November 2019 - Arbitration in determining prescription drug prices is a viable mechanism to address the burden of high ...
Posted by Michael Wonder on 19 Nov 2019
Elizabeth Warren says ‘Medicare for All’ rollout process will take 3 years
16 November 2019 — Elizabeth Warren announced Friday that she would expand public health insurance during her first 100 days ...
Posted by Michael Wonder on 19 Nov 2019
Drug cost legislation gets a push from White House
18 November 2019 - The White House is ramping up its push to get a bill through Congress that curbs ...